2024 and Packaging - Pharmacy Technician Pulse

Sustainability continues to steer pharmaceutical packaging market

European Pharmaceutical Review

NOVEMBER 1, 2024

The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12 billion by 2033, according to a study published by Towards Packaging. percent between 2024 and 2033. Specifically, the “high quality of biodegradable and recyclable packaging materials” are driving the market.

Packaging

Packaging Pharmaceutical Companies Dosage Pharmaceutical Companies

Independent Pharmacists’ Unique Role During Disaster Management Efforts

Drug Topics

JUNE 11, 2025

From 1980 to 2024, the National Centers for Environmental Information reported 403 confirmed natural disaster events impacting weather or climate, totaling economic losses over $1 billion. One of the most recent natural disasters was the late-2024 and early-2025 Los Angeles wildfires.

Health and Personal Care Stores

Health and Personal Care Stores Community Pharmacies Independent Pharmacies Communication

Help Turn Occasional Shoppers into Loyal Customers by Investing in the Front End

Drug Topics

JULY 10, 2025

PwC’s 2024 Voice of the Customer report found that 80% of consumers are willing to pay more for sustainably produced or sourced goods, despite overall rising costs. sustainability premium, even as cost-of-living and inflationary concerns weigh: PwC 2024 Voice of the Consumer Survey. April 2025. Consumers willing to pay 9.7%

Health and Personal Care Stores

Health and Personal Care Stores Independent Pharmacies Labelling Specialty Pharmacies

FDA Approves Insulin Aspart-Xjhz as First Interchangeable Biosimilar to NovoLog

Drug Topics

JULY 21, 2025

May 15, 2024. Kirsty [package insert]. Biocon Biologics expands diabetes portfolio with FDA approval of Kirsty, the first and only interchangeable rapid-acting insulin aspart in the United States. News release. Biocon Biologics. July 15, 2025. Accessed July 21, 2025. National Diabetes Statistics Report. Accessed July 21, 2025.

FDA

FDA Specialty Pharmacies Compounding Hospitals

Five Interesting Things To Know About Sulopenem (Orlynvah)

IDStewardship

JANUARY 13, 2025

BCIDP UNDER CONSTRUCTION Article PostedXXX Sulopenem etzadroxil and probenecid (Orlynvah) was recently approved in October 2024 for the treatment of uncomplicated urinary tract infections (uUTI) caused by Escherichia coli , Klebsiella pneumoniae , or Proteus mirabilis. 2024 Nov 2:S1198-743X(24)00507- X. Orlynvah [package insert].

Packaging

Packaging Labelling FDA

Megablockbusters are the holy grail. Here’s how drugmakers are getting there.

PharmaVoice

JUNE 23, 2025

Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Megablockbusters are the holy grail.

Packaging

New biosimilar pathways – key takeaways from the EMA’s draft reflection paper

European Pharmaceutical Review

JUNE 19, 2025

4,5,6 However, these benefits are contingent on the ability to generate comprehensive, high-quality analytical and PK data packages. 10 The package, once adopted, is expected to introduce changes to regulatory exclusivity, market access, and competition rules for medicines, including biosimilars, across the EU. 2020;25(11):1910-1918.

Packaging

Packaging Documentation

Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report

Pharmafile

JANUARY 14, 2025

Pharmapack Europe: Basel the best location for drug device innovation in Europe thanks to combination of world class manufacturing and existing biomedical research infrastructure 18 December 2024 Paris, France New research released ahead of Pharmapack Europe the continents largest partnering event for medical device and packaging innovation has (..)

Packaging

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Pharmaceutical Technology

JUNE 19, 2025

Innovator oligonucleotide-based drugs targeting central nervous system (CNS) indications witnessed a 339% ($2.17bn) increase in total licensing agreement deal value from 2023 to 2024, reaching a total deal value of $2.81bn, according to GlobalData’s Pharma Intelligence Center Deals Database.

Communication

Communication Hospitals Packaging Pharmaceutical Companies

C-suite shuffles ripple through pharma

PharmaVoice

JULY 31, 2025

While the company touted Perry’s 30 years of leadership in consumer packaged goods, it said an executive search firm has been hired to lead the quest for its next permanent CEO. In its preliminary earnings report for the most recent quarter, Kenvue said it expects a 4% sales drop.

FDA

FDA Packaging Compounding Insurance

The European Market Access Lag: 2021–2024

Pharmaceutical Technology

JUNE 9, 2025

On average, 58% of branded drugs approved between 2021 and 2024 in Europe have either fully or restricted reimbursement. First, the access landscape for 220 originator medicines approved by the EMA between 2021–2024 was assessed. Reimbursement status for each brand per European market was analysed during this period.

Communication

Communication Hospitals Packaging Insurance

GLP-1 roadblocks: Discontinuation rates soar as insurers clamp down

PharmaVoice

JULY 7, 2025

Estimates vary for how many patients with either obesity or diabetes stop using the drugs, but one 2024 study pegged the discontinuation between 50% and 75% within a year. Discontinuation rates soar The high rate of discontinuation among GLP-1 users remains a prime burden to keeping patients on the drugs.

Insurance

Insurance Compounding Packaging FDA

How AI and machine learning are transforming drug discovery

Pharmaceutical Technology

JUNE 26, 2025

Indeed, in 2024, the Nobel Prize in Chemistry was awarded to the DeepMind team for their work on AlphaFold [ii] , an AI system that accurately predicts protein structures. link] [iv] [link] [v] [link] [vi] GlobalData: Artificial Intelligence in Healthcare, September 2024 [vii] QuantumPharm Inc 2024, prospectus. Front Genet.

Compounding

Compounding Communication Packaging Labelling

UK enacts law to decentralise manufacture of personalised treatments

Pharmaceutical Technology

JULY 23, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights.

Communication

Communication Hospitals Packaging Insurance

Pharmaceutical Technology Excellence Awards 2025: i3 Membrane

Pharmaceutical Technology

JUNE 24, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in Harbour BioMed partners Otsuka on new T-cell therapy Madrigal poised to enter European MASH market after CHMP endorsement Themes Sections Artificial Intelligence Cloud Corporate Governance (..)

Packaging

Packaging Pharmaceutical Companies Pharmaceutical Companies

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

European Pharmaceutical Review

APRIL 10, 2025

These chemicals are everywhere and have been used in many ways over the decades, bringing a range of benefits from water- and stain-resistant coatings and firefighting foams to nail polish and food packaging. However, the world is now learning they are also persistent pollutants that contaminate our soil, water and air. CHEM Trust.

Packaging

Packaging Documentation Communication

Hengrui Pharma and GSK link across key therapeutic areas

Pharmaceutical Technology

JULY 28, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Insurance

BASF Opens GMP Manufacturing Facility in Michigan

PharmTech

JUNE 19, 2025

The new facility will feature state-of-the-art cleanroom packaging and high-sensitivity analytical testing capabilities. Drug Solutions Podcast: Growth and Advancements in Fill/Finish Felicity Thomas June 25th 2024 Podcast In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish. PharmTech.com.

Dosage

Dosage Packaging FDA Communication

Pharmacy Law and Licensing Highlights 2025

The FDA Law Blog

FEBRUARY 2, 2025

By Sara M Keup In reviewing some new 2025 pharmacy rules/laws a couple interesting changes caught this bloggers attention: As of December 30, 2024, Missouri has rolled out new rules related to prescription drug delivery requirements. The California Board of Pharmacy updated many of the application forms and guidelines in late 2024.

Packaging

Packaging Documentation Compounding

Bora Pharmaceuticals to Expand Midwest Manufacturing Site

PharmTech

AUGUST 7, 2025

The investment will expand the company’s manufacturing and packaging capabilities at its Maple Grove, Minn. site, which Bora acquired in 2024 with its acquisition of Upsher-Smith Laboratories.

Packaging

GSK’s world-first gonorrhoea vaccine launched in England

Pharmaceutical Technology

AUGUST 5, 2025

Give your business an edge with our leading industry insights.

Vaccines

Vaccines Communication Hospitals Packaging

FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid

Pharmaceutical Technology

JUNE 25, 2025

Give your business an edge with our leading industry insights.

FDA

FDA Packaging Communication Hospitals

The MEK effect on cancer — a slow and steady approach to drug resistance

PharmaVoice

JULY 8, 2025

Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from The MEK effect on cancer — a slow and steady (..)

Immunization

Immunization Chemotherapy Insurance Packaging

Flow state: The evolving shape of continuous manufacturing

Pharma Manufacturing

JUNE 17, 2025

According to the results of CRB’s Horizons: Life Sciences survey released in October 2024, 75% of respondents are using or plan to use continuous technologies almost exclusively within the next five years, based on a survey of 500 industry leaders including therapeutic developers and CDMO executives.

Dosage

Dosage FDA Packaging

Six Biosimilars Part of EMA’s Authorization Recommendations in June

PharmTech

JUNE 23, 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish Felicity Thomas June 25th 2024 Podcast In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Dosage

Dosage Chemotherapy Packaging

MetrioPharm gains orphan drug status from EMA for MP1032

Pharmaceutical Technology

JULY 30, 2025

Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Immunization FDA

ICH Q6B for Analytics

PharmTech

JUNE 6, 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish Felicity Thomas June 25th 2024 Podcast In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish. With their technical and methodological improvements, advanced techniques provide valuable information on overall product mass profiles.

Dosage

Dosage Documentation Labelling FDA

HS market forecast to reach $7.8bn across 7MM by 2034

Pharmaceutical Technology

JULY 28, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Market growth will be led by the US, which accounted for over 70% of HS sales in 2024 due to a larger diagnosed population, broader biologic access, and premium pricing.

Packaging

Packaging Communication Hospitals Compounding

Hypertension: A Silent Killer Requiring Novel Therapies

Pharmacy Times

JULY 19, 2025

2024 ESC guidelines for the management of elevated blood pressure and hypertension. doi:10.1016/20S0140-6736(22)02034-7 Aprocitentan (Tryvio) package insert. Widaplik (telmisartan, amlodipine, indapamide) package insert. J Am Coll Cardiol. 2018;71:e127-e248. doi:10.1016/j.jacc.2017.11.006 Eur Heart J. 2018; 39: 3021–3104.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Compounding Pharmacies Vaccines Immunization

Vutrisiran marks first silencer approved for ATTR-CM

Pharmaceutical Technology

JUNE 12, 2025

Give your business an edge with our leading industry insights.

Communication

Communication Hospitals Packaging Insurance

Is biopharma dealmaking getting hot again?

PharmaVoice

JULY 8, 2025

Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Is biopharma dealmaking getting hot again?

Insurance

Insurance Packaging Immunization

3 of the year’s most notable FDA nods

PharmaVoice

JUNE 27, 2025

FDA approvals dropped in May to 14 drugs after hitting 20 and above in the two months prior, but the total of 84 OKs so far in 2025 is the second only to 2024’s record high for the first part of the year, according to Clarivate.

FDA

FDA Vaccines Packaging Dosage

Fosun and Expedition make $645m licensing deal for respiratory drug

Pharmaceutical Technology

AUGUST 12, 2025

Give your business an edge with our leading industry insights.

Packaging

Packaging Compounding Communication Hospitals

FDA gives Arvinas and Pfizer’s vepdegestrant NDA for breast cancer

Pharmaceutical Technology

AUGUST 11, 2025

Give your business an edge with our leading industry insights.

FDA

FDA Packaging Communication Hospitals

A pharmacist’s take on actions from the child asthma and anaphylaxis deaths report

Hospital Pharmacy Europe

APRIL 14, 2025

The National Child Mortality Database report on child deaths related to asthma and allergies was released in December 2024, providing sobering insights. Of those, the most common factor was unclear, misleading, or inaccurate food labelling (either packaged or cooked, bought from supermarkets or takeaways). Accessed March 2025].

Health and Personal Care Stores

Health and Personal Care Stores Hospitals Communication Packaging

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Pharmaceutical Technology

JUNE 13, 2025

Give your business an edge with our leading industry insights.

Vaccines

Vaccines Communication Hospitals Packaging

Mosanna Therapeutics gains $80m to advance OSA nasal spray

Pharmaceutical Technology

JUNE 10, 2025

Give your business an edge with our leading industry insights.

Communication

Communication Hospitals Packaging Insurance

Alfasigma sets stage for Jyseleca in axSpA after Phase III win

Pharmaceutical Technology

JULY 29, 2025

In January 2024, the drug was transferred by Galapagos to Alfasigma, with Galapagos having received a €50m ($57.89m) upfront payment and is in line for potential sales-based milestone payments of €120m and mid-single to mid-double-digit royalties on European sales. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Insurance

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

PharmTech

JUNE 23, 2025

From the Dilantin package insert: “The free acid form of phenytoin is used in DILANTIN-125 Suspension and DILANTIN Infatabs. Pharmaceutical Technology Trends in Manufacturing eBook May 2024. Selecting of the appropriate pharmaceutical alternative requires technical judgment. Mancini, A. Thakar, N. and Chaiyaperm, V.

Compounding

Compounding Dosage Labelling FDA

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

Pharmaceutical Technology

JULY 1, 2025

Experts praise the reforms to rare disease and antimicrobial research, but they worry that some provisions in the EU Pharma Package may harm innovation on the continent, contrary to its stated objectives. In a bid to chase competitiveness, the EU is advancing its most drastic revision of pharmaceutical law in 20 years.

Packaging

Packaging Chemotherapy Communication Hospitals

Pharma’s turbo spending spree on US manufacturing

PharmaVoice

JULY 24, 2025

All told, AstraZeneca aims to boost its total revenue from the $54 billion -mark it hit in 2024 to over $80 billion by 2030 — half of which it expects to be generated in the U.S., The American market for drugs also plays a starring role in the company’s broader ambitions. the company said.

Packaging

Packaging FDA

To Combat Medication Errors, Proper Pharmacy Inventory Counts Are Essential

Pharmacy Times

JUNE 5, 2025

Detect-A-Dose lid-label cover enhances medication recognition, reducing packaging errors through a contrasting visual pattern. 2 A prominent aspect of this issue that manufacturers have tried to tackle is medication recognition when transferring pills to containers and packaging. 1-3 Detect-A-Dose Lid Label Covers.

Packaging

Packaging Labelling Compounding Pharmacies Immunization

Big pharma braces for revenue headwinds as patent expiries loom

Pharmaceutical Technology

JULY 4, 2025

Only 4% of global drugs sales will have patent protection, compared to 12% and 6% in 2022 and 2024. Keytruda, approved to treat a range of solid tumours, was the top selling drug in the world in 2024, netting over $29bn in annual sales. How will RFK Jr’s American dream for vaccines play out?

Chemotherapy

Chemotherapy Packaging Communication Hospitals

Orion and Glykos extend ADC collaboration

Pharmaceutical Technology

JUNE 18, 2025

The financial conditions outlined in the extended agreement covering the three new ADC projects remain consistent with those specified in the original agreement signed in January 2024 for the initial three projects. In September 2024, Orion entered a partnership with Aitia to leverage AI in drug discovery and simulation in the oncology field.

Communication

Communication Hospitals Packaging Insurance

Sustainability continues to steer pharmaceutical packaging market

Independent Pharmacists’ Unique Role During Disaster Management Efforts

Trending Sources

Help Turn Occasional Shoppers into Loyal Customers by Investing in the Front End

FDA Approves Insulin Aspart-Xjhz as First Interchangeable Biosimilar to NovoLog

Five Interesting Things To Know About Sulopenem (Orlynvah)

Megablockbusters are the holy grail. Here’s how drugmakers are getting there.

New biosimilar pathways – key takeaways from the EMA’s draft reflection paper

Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

C-suite shuffles ripple through pharma

The European Market Access Lag: 2021–2024

GLP-1 roadblocks: Discontinuation rates soar as insurers clamp down

How AI and machine learning are transforming drug discovery

UK enacts law to decentralise manufacture of personalised treatments

Pharmaceutical Technology Excellence Awards 2025: i3 Membrane

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

Hengrui Pharma and GSK link across key therapeutic areas

BASF Opens GMP Manufacturing Facility in Michigan

Pharmacy Law and Licensing Highlights 2025

Bora Pharmaceuticals to Expand Midwest Manufacturing Site

GSK’s world-first gonorrhoea vaccine launched in England

FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid

The MEK effect on cancer — a slow and steady approach to drug resistance

Flow state: The evolving shape of continuous manufacturing

Six Biosimilars Part of EMA’s Authorization Recommendations in June

MetrioPharm gains orphan drug status from EMA for MP1032

ICH Q6B for Analytics

HS market forecast to reach $7.8bn across 7MM by 2034

Hypertension: A Silent Killer Requiring Novel Therapies

Vutrisiran marks first silencer approved for ATTR-CM

Is biopharma dealmaking getting hot again?

3 of the year’s most notable FDA nods

Fosun and Expedition make $645m licensing deal for respiratory drug

FDA gives Arvinas and Pfizer’s vepdegestrant NDA for breast cancer

A pharmacist’s take on actions from the child asthma and anaphylaxis deaths report

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Mosanna Therapeutics gains $80m to advance OSA nasal spray

Alfasigma sets stage for Jyseleca in axSpA after Phase III win

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

Pharma’s turbo spending spree on US manufacturing

To Combat Medication Errors, Proper Pharmacy Inventory Counts Are Essential

Big pharma braces for revenue headwinds as patent expiries loom

Orion and Glykos extend ADC collaboration

Stay Connected